Mary Agoglia Hoeltzel - May 14, 2024 Form 4 Insider Report for Cigna Group (CI)

Signature
Matthew Arnold, attorney-in-fact
Stock symbol
CI
Transactions as of
May 14, 2024
Transactions value $
-$1,354,608
Form type
4
Date filed
5/16/2024, 05:22 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $719K +5.95K +229.16% $120.90 8.54K May 14, 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Sale -$2.07M -5.95K -69.62% $348.71 2.59K May 14, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -5.95K -100% $0.00* 0 May 14, 2024 Common Stock, $.01 Par Value 5.95K $120.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 8.414 shares of common stock received from her participation in a dividend reinvestment plan.
F2 Represents the weighted average price of the shares sold. The prices actually received ranged from $348.68 to $349.01 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F3 This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.